# EDGAR Filing Document

**Accession Number:** 0002011053
**File Stem:** 0001641172-25-014325
**Filing Date:** 2025-6
**Character Count:** 9585
**Document Hash:** 88b25987a0cbdf84a0cb4298b2a2db89
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-014325.hdr.sgml**: 20250609

**ACCESSION NUMBER**: 0001641172-25-014325

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250609

**FILED AS OF DATE**: 20250609

**DATE AS OF CHANGE**: 20250609

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SolarBank Corp
- **CENTRAL INDEX KEY:** 0002011053
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRIC & OTHER SERVICES COMBINED [4931]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41976
- **FILM NUMBER:** 251034521

**BUSINESS ADDRESS:**
- **STREET 1:** 505 CONSUMERS ROAD
- **STREET 2:** SUITE 803
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M2J 4V8
- **BUSINESS PHONE:** 1-416-494-9559

**MAIL ADDRESS:**
- **STREET 1:** 505 CONSUMERS ROAD
- **STREET 2:** SUITE 803
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M2J 4V8

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE**

**SECURITIES EXCHANGE ACT OF 1934**

For the month of June, 2025.

Commission File Number 001-41976

**<u>Solarbank Corporation</u>**

(Translation of registrant's name into English)

**505 Consumers Rd., Suite 803**

**<u>Toronto, Ontario, M2J 4Z2 Canada</u>**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☒

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) ☐

Indicate by check mark if the registrant is "submitting" the Form 6-K in paper as permitted by Regulation S-T "Rule" 101(b)(7) **☐**

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date June 9, 2025 | **Solarbank Corporation** | **Solarbank Corporation** |
|  | By: | */s/ Sam Sun* |
|  |  | Sam Sun |
|  |  | Chief Financial Officer & Corporate Secretary |

---

**Exhibit Index**

---

| | |
|:---|:---|
| **Exhibit** | **Description of Exhibit** |
| 99.1 | [Material Change Report dated June 9, 2025](ex99-1.htm) |

---

## Exhibit 99.1

**Exhibit 99.1**

**FORM 51-102F3** 

**MATERIAL CHANGE REPORT**

1. Name and Address of Company

SolarBank Corporation (the "**Company**" or "**SolarBank**") 505 Consumers Road, Suite 803

Toronto, Ontario M2J 4Z2

2. Date of Material Change

June 5, 2025

3. News Release

A news release announcing the material change was disseminated on June 5, 2025 via Cision.

4. Summary of Material Change

The Company announced that it has entered into an equity distribution agreement (the "**Distribution Agreement**") with H.C. Wainwright & Co., LLC ("**Wainwrigh**t"), Research Capital Corporation ("**RCC**"), Research Capital USA Inc. (together with Wainwright and RCC, the "**Agents**") to renew the Company's at-the-market equity program (the "**ATM Program**").

5.1 Full Description of Material Change

The Company announced that it had entered into the Distribution Agreement with the Agents to renew the ATM Program. There can be no assurance that the Company will issue and sell any common shares under the ATM Program. The timing of any sales and the number of shares sold, if any, will depend on a variety of factors to be determined by the Company.

Under the Distribution Agreement, the Company may issue common shares of the Company having an aggregate offering price of up to US$15,000,000 (the "**Offered Shares**") under the ATM Program. The Offered Shares will be issued by the Company to the public from time to time, through the Agents, at the Company's discretion. The Offered Shares sold under the ATM Program, if any, will be sold at the prevailing market price at the time of sale. Since the Offered Shares will be distributed at trading prices prevailing at the time of the sale, prices may vary between purchasers and during the period of distribution. The Company intends to use the net proceeds from sales of Offered Shares under the ATM Program, if any, to advance the Company's business objectives and for general corporate purposes, including, without limitation, funding ongoing operations or working capital requirements, repaying indebtedness outstanding from time to time, discretionary capital programs and potential future acquisitions.

Sales of Offered Shares, if any, will be made through the Agents in transactions that are deemed to be "at- the-market distributions" as defined in National Instrument 44-102 – *Shelf Distributions* and an "at-the-market offering" as defined in Rule 415(a)(4) under the United States Securities Act of 1933, as amended, on the Cboe Canada Inc. and the Nasdaq Stock Market, or any other applicable "marketplace" for the common shares in Canada. The Company is not obligated to make any sales of Offered Shares under the Distribution Agreement.. The Company will pay the Agents a commission of up to 3.0% of the gross offering proceeds from each sale of Offered Shares and has agreed to provide the Agents with customary indemnification and contribution rights. The Company will also reimburse the Agents for certain specified expenses in connection with the entering into and performance of the Distribution Agreement.

The ATM Program is being made in Canada pursuant to a prospectus supplement dated June 5, 2025 (the "**Prospectus Supplement**") to the Company's final short form base shelf prospectus dated May 7, 2025 (the "**Base Prospectus**"), and in the United States pursuant to a prospectus supplement dated June 5, 2025 (the "**U.S. Prospectus Supplement**") to the Company's final base shelf prospectus contained in the Company's effective registration statement on Form F-10 (File No. 333-287070) (the "**Registration Statement**") filed with the United States Securities and Exchange Commission (the "**SEC**"). Prospective investors should read the Base Prospectus, the Prospectus Supplement and other documents the Company has filed with the SEC (some of which are incorporated by reference into the Base Prospectus and the Prospectus Supplement) for more complete information about the Company and the ATM Program, including the risks associated with investing in the Company.

5.2 Disclosure for Restructuring Transactions

Not Applicable

6. Reliance on Section 7.1(2) of National Instrument 51-102

Not Applicable

7. Omitted Information

Not Applicable

8. Executive Officer

The name and business number of the executive officer of the Company who is knowledgeable about the material change and this report is:

Sam Sun, Chief Financial Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(416) 494-9559

<u>sam.sun@solarbankcorp.com</u>

9. Date of Report

June 9, 2025

**FORWARD-LOOKING STATEMENTS**

This material change report contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, "**forward-looking statements**") that relate to the Company's current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as "will likely result", "are expected to", "expects", "will continue", "is anticipated", "anticipates", "believes", "estimated", "intends", "plans", "forecast", "projection", "strategy", "objective" and "outlook") are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. In particular and without limitation, this material change report contains forward-looking statements including statements with respect to the Offered Shares sold under the ATM Program; the use of proceeds from any such sale of Offered Shares; the use by the Company of the ATM Program; future development, production, cash flow and other anticipated or possible future developments of the Company's business as well as those listed under *"Caution Regarding Forward- Looking Statements" and "Risk Factors*" in the Base Prospectus, and other public filings of the Company. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this material change report should not be unduly relied upon. These statements speak only as of the date of this material change report.

The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them, or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this material change report are expressly qualified in their entirety by this cautionary statement.